The Medicines and Healthcare Products Regulatory Agency (MHRA) based in the United Kingdom recently revealed that the European Union (EU) is recommending that it should suspend imports and exports of certain medicines for oral use that were manufactured by a company called Ranbaxy.
This recommendation was made after revelations from the FDA of India, where they have found widespread evidence of data manipulation and fabrication at Ranbaxy plants in India. The data indicated poor quality control.
The MHRA has decided to consider the EU’s request to suspend trade with these medicines manufactured by Ranbaxy while they conduct their own investigations into the matter.
The MHRA are conducting their own thorough investigation into this matter, but in the meantime, they consider it prudent to recommend that the EU should suspend all imports and exports of oral liquid medicines manufactured by Ranbaxy. These recommendations were made following advice from Indian authorities.
This decision is without prejudice to any further action which may be decided upon as a result of the MHRA investigation. This decision is restricted to medicines manufactured in the plant at Dewas and does not extend to any other Ranbaxy products or plants.
Disclaimer: The contents of this site, such as text, graphics, images, and other materials contained on the page are for general information purposes only. This article is not a substitute for professional advice on the topics mentioned. This article does not create any form of offers to any legal or professional service. The site assumes no responsibility for errors or omissions in the contents. In no event shall the site be liable for any special, direct, indirect, consequential, or incidental damages or any damages whatsoever, whether in an action to follow the content, negligence or other tort, arising out of the use of the contents of the article. The blog reserves the right to make additions, deletions, or modifications to the contents at any time without prior notice. The site does not warrant that the site is free of viruses or other harmful components. It may contain views and opinions which are those of the authors and do not necessarily reflect the official policy or position of any other author, agency, organization, employer or company, including the site itself. It also does not provide professional advice, diagnosis, treatment or any legal service. The site does not endorse official procedures, legal actions or qualified services and the use of its contents are solely at your own risk.